Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Periso is a Swiss medical technology company specializing in the development and manufacturing of advanced devices for diamagnetic therapy. The company's flagship technology, the CTU Mega 20, utilizes high-intensity, low-frequency magnetic fields to treat musculoskeletal disorders and accelerate tissue repair. Periso's products are widely used in physical therapy, sports medicine, and rehabilitation centers to manage pain, inflammation, and edema non-invasively. By leveraging the diamagnetic properties of biological tissues, their devices facilitate the movement of liquids and the stimulation of cellular processes. Founded in 1987, the company maintains a strong presence in Europe and continues to innovate in the field of physical medicine through the integration of electronics and magnetism.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Periso.